Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration ; volume:23 ; number:1 ; day:26 ; month:4 ; year:2019 ; pages:1-3 ; date:12.2019
Critical care ; 23, Heft 1 (26.4.2019), 1-3, 12.2019
- Urheber
-
Aguilar, Gerardo
Ferriols, Rafael
Martínez-Castro, Sara
Ezquer, Carlos
Pastor, Ernesto
Carbonell, José A.
Alós, Manuel
Navarro, David
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-019-2434-5
- URN
-
urn:nbn:de:101:1-2019051921470542331033
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aguilar, Gerardo
- Ferriols, Rafael
- Martínez-Castro, Sara
- Ezquer, Carlos
- Pastor, Ernesto
- Carbonell, José A.
- Alós, Manuel
- Navarro, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
Plasma Mitochondrial DNA Clearance by Continuous Venovenous Haemofiltration in Critically Ill Patients
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Tazobactam-Piperacillin : mit 102 Tabellen
Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
Plasma Mitochondrial DNA Clearance by Continuous Venovenous Haemofiltration in Critically Ill Patients
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Tazobactam-Piperacillin : mit 102 Tabellen
Extended infusion of piperacillin–tazobactam versus intermittent infusion in critically ill egyptian patients: a cost-effectiveness study
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis
Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients
We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients
The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
Plasma Mitochondrial DNA Clearance by Continuous Venovenous Haemofiltration in Critically Ill Patients
An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Tazobactam-Piperacillin : mit 102 Tabellen